Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysis
PM in mUM patients is rare and in contrast to other extra-abdominal tumors does not worsen prognosis. Prognosis is greatly influenced by the metastatic pattern, which is determined by tumor biology, as evidenced by its correlation with genetic risk groups and TMB.
Authors
- Stanislav Rosnev (ORCID: https://orcid.org/0000-0003-0256-7038)
- Markus Möbs (ORCID: https://orcid.org/0000-0002-1502-3032)
- Iris Piwonski
- Ulrich Bernd Keller (ORCID: https://orcid.org/0000-0002-8485-1958)
- Serge Leyvraz (ORCID: https://orcid.org/0000-0002-5705-6799)
- Sebastian Ochsenreither (ORCID: https://orcid.org/0000-0001-6024-4312)
- Maximilian de Bucourt (ORCID: https://orcid.org/0000-0002-6244-0496)
- Jana Ihlow (ORCID: https://orcid.org/0000-0001-5484-1321)
- Jonas Klingberg
- Caroline Anna Peuker (ORCID: https://orcid.org/0000-0002-0957-2166)
- Ulrich Keilholz (ORCID: https://orcid.org/0000-0001-6773-9406)
- David Horst (ORCID: https://orcid.org/0000-0003-4755-5743)
- Susanne M. Rittig (ORCID: https://orcid.org/0000-0001-6708-9685)
- Maria Joosten (ORCID: https://orcid.org/0000-0001-9059-9675)
- Antonia Maria Joussen
Institutions
- German Cancer Research Center (DE)
- Max Delbrück Center (DE)
- Heidelberg University (DE)
- Humboldt-Universität zu Berlin (DE)
- German Cancer Society (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1016/j.ejca.2025.115280
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Stiftung Charité
- Berlin Institute of Health